Annual D&A
$1.39 M
+$271.00 K+24.15%
December 31, 2023
Summary
- As of February 12, 2025, SAGE annual depreciation & amortization is $1.39 million, with the most recent change of +$271.00 thousand (+24.15%) on December 31, 2023.
- During the last 3 years, SAGE annual D&A has fallen by -$1.24 million (-47.03%).
- SAGE annual D&A is now -66.69% below its all-time high of $4.18 million, reached on December 31, 2021.
Performance
SAGE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$255.00 K
-$56.00 K-18.01%
September 30, 2024
Summary
- As of February 12, 2025, SAGE quarterly depreciation & amortization is $255.00 thousand, with the most recent change of -$56.00 thousand (-18.01%) on September 30, 2024.
- Over the past year, SAGE quarterly D&A has dropped by -$56.00 thousand (-18.01%).
- SAGE quarterly D&A is now -90.12% below its all-time high of $2.58 million, reached on March 31, 2021.
Performance
SAGE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.31 M
-$75.00 K-5.41%
September 30, 2024
Summary
- As of February 12, 2025, SAGE TTM depreciation & amortization is $1.31 million, with the most recent change of -$75.00 thousand (-5.41%) on September 30, 2024.
- Over the past year, SAGE TTM D&A has dropped by -$75.00 thousand (-5.41%).
- SAGE TTM D&A is now -72.54% below its all-time high of $4.77 million, reached on June 30, 2021.
Performance
SAGE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
SAGE Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +24.1% | -18.0% | -5.4% |
3 y3 years | -47.0% | -31.8% | -70.8% |
5 y5 years | +21.9% | -63.5% | -42.6% |
SAGE Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -66.7% | +24.1% | -37.6% | at low | -68.7% | +16.8% |
5 y | 5-year | -66.7% | +24.1% | -90.1% | at low | -72.5% | +16.8% |
alltime | all time | -66.7% | +3065.9% | -90.1% | +2218.2% | -72.5% | >+9999.0% |
Sage Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $255.00 K(-18.0%) | $1.31 M(-5.4%) |
Jun 2024 | - | $311.00 K(-7.4%) | $1.39 M(-1.4%) |
Mar 2024 | - | $336.00 K(-17.8%) | $1.41 M(+0.9%) |
Dec 2023 | $1.39 M(+24.2%) | $409.00 K(+23.9%) | $1.39 M(+9.3%) |
Sep 2023 | - | $330.00 K(-0.3%) | $1.27 M(+4.3%) |
Jun 2023 | - | $331.00 K(+2.5%) | $1.22 M(+4.4%) |
Mar 2023 | - | $323.00 K(+11.4%) | $1.17 M(+4.3%) |
Dec 2022 | $1.12 M(-73.2%) | $290.00 K(+4.3%) | $1.12 M(-3.7%) |
Sep 2022 | - | $278.00 K(-0.4%) | $1.17 M(-7.6%) |
Jun 2022 | - | $279.00 K(+1.5%) | $1.26 M(-32.7%) |
Mar 2022 | - | $275.00 K(-17.4%) | $1.88 M(-55.2%) |
Dec 2021 | $4.18 M(+59.0%) | $333.00 K(-11.0%) | $4.18 M(-7.0%) |
Sep 2021 | - | $374.00 K(-58.1%) | $4.50 M(-5.8%) |
Jun 2021 | - | $893.00 K(-65.4%) | $4.77 M(+5.1%) |
Mar 2021 | - | $2.58 M(+297.8%) | $4.54 M(+72.7%) |
Dec 2020 | $2.63 M(+15.2%) | $649.00 K(-0.2%) | $2.63 M(-0.6%) |
Sep 2020 | - | $650.00 K(-1.8%) | $2.65 M(-1.8%) |
Jun 2020 | - | $662.00 K(-1.0%) | $2.69 M(+6.2%) |
Mar 2020 | - | $669.00 K(+0.6%) | $2.54 M(+11.1%) |
Dec 2019 | $2.28 M(+99.7%) | $665.00 K(-4.7%) | $2.28 M(+15.2%) |
Sep 2019 | - | $698.00 K(+38.2%) | $1.98 M(+26.2%) |
Jun 2019 | - | $505.00 K(+21.7%) | $1.57 M(+19.8%) |
Mar 2019 | - | $415.00 K(+14.3%) | $1.31 M(+14.7%) |
Dec 2018 | $1.14 M | $363.00 K(+26.5%) | $1.14 M(+24.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2018 | - | $287.00 K(+16.7%) | $915.00 K(+19.8%) |
Jun 2018 | - | $246.00 K(-0.4%) | $764.00 K(+17.9%) |
Mar 2018 | - | $247.00 K(+83.0%) | $648.00 K(+22.0%) |
Dec 2017 | $531.00 K(+89.0%) | $135.00 K(-0.7%) | $531.00 K(+11.1%) |
Sep 2017 | - | $136.00 K(+4.6%) | $478.00 K(+12.5%) |
Jun 2017 | - | $130.00 K(0.0%) | $425.00 K(+14.9%) |
Mar 2017 | - | $130.00 K(+58.5%) | $370.00 K(+31.7%) |
Dec 2016 | $281.00 K(+144.3%) | $82.00 K(-1.2%) | $281.00 K(+21.6%) |
Sep 2016 | - | $83.00 K(+10.7%) | $231.00 K(+30.5%) |
Jun 2016 | - | $75.00 K(+82.9%) | $177.00 K(+32.1%) |
Mar 2016 | - | $41.00 K(+28.1%) | $134.00 K(+16.5%) |
Dec 2015 | $115.00 K(+125.5%) | $32.00 K(+10.3%) | $115.00 K(+16.2%) |
Sep 2015 | - | $29.00 K(-9.4%) | $99.00 K(+19.3%) |
Jun 2015 | - | $32.00 K(+45.5%) | $83.00 K(+33.9%) |
Mar 2015 | - | $22.00 K(+37.5%) | $62.00 K(+21.6%) |
Dec 2014 | $51.00 K(+8.5%) | $16.00 K(+23.1%) | $51.00 K(+6.3%) |
Sep 2014 | - | $13.00 K(+18.2%) | $48.00 K(+4.3%) |
Jun 2014 | - | $11.00 K(0.0%) | $46.00 K(-2.1%) |
Mar 2014 | - | $11.00 K(-15.4%) | $47.00 K(0.0%) |
Dec 2013 | $47.00 K(+6.8%) | $13.00 K(+18.2%) | $47.00 K(+38.2%) |
Sep 2013 | - | $11.00 K(-8.3%) | $34.00 K(+47.8%) |
Jun 2013 | - | $12.00 K(+9.1%) | $23.00 K(+109.1%) |
Mar 2013 | - | $11.00 K | $11.00 K |
Dec 2012 | $44.00 K | - | - |
FAQ
- What is Sage Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Sage Therapeutics?
- What is Sage Therapeutics annual D&A year-on-year change?
- What is Sage Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sage Therapeutics?
- What is Sage Therapeutics quarterly D&A year-on-year change?
- What is Sage Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Sage Therapeutics?
- What is Sage Therapeutics TTM D&A year-on-year change?
What is Sage Therapeutics annual depreciation & amortization?
The current annual D&A of SAGE is $1.39 M
What is the all time high annual D&A for Sage Therapeutics?
Sage Therapeutics all-time high annual depreciation & amortization is $4.18 M
What is Sage Therapeutics annual D&A year-on-year change?
Over the past year, SAGE annual depreciation & amortization has changed by +$271.00 K (+24.15%)
What is Sage Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SAGE is $255.00 K
What is the all time high quarterly D&A for Sage Therapeutics?
Sage Therapeutics all-time high quarterly depreciation & amortization is $2.58 M
What is Sage Therapeutics quarterly D&A year-on-year change?
Over the past year, SAGE quarterly depreciation & amortization has changed by -$56.00 K (-18.01%)
What is Sage Therapeutics TTM depreciation & amortization?
The current TTM D&A of SAGE is $1.31 M
What is the all time high TTM D&A for Sage Therapeutics?
Sage Therapeutics all-time high TTM depreciation & amortization is $4.77 M
What is Sage Therapeutics TTM D&A year-on-year change?
Over the past year, SAGE TTM depreciation & amortization has changed by -$75.00 K (-5.41%)